PuSH - Publikationsserver des Helmholtz Zentrums München

Wendtner, C.-M.* ; Abdel-Rahman, S.* ; Krych, M.* ; Baumert, J.J.* ; Lindner, L.H.* ; Baur, A.* ; Hiddemann, W.* ; Issels, R.D.

Response to Neoadjuvant Chemotherapy Combined with Regional Hyperthermia Predicts Long-Term Survival for Adult Patients with Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas.

J. Clin. Oncol. 20, 3156-3164 (2002)
Purpose: To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for local tumor control and overall survival (OS) in adult patients with retroperitoneal or visceral (RP/V) high-risk soft tissue sarcomas (HR-STS).Patients and Methods: From 1991 to 1997, 58 patients with HR-STS at RP/V sites were prospectively treated with four cycles of etoposide, ifosfamide, and doxorubicin combined with RHT followed by surgery, adjuvant chemotherapy, and radiation.
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter PROGNOSTIC FACTORS; PHASE-II; PREOPERATIVE CHEMOTHERAPY; RADIOTHERAPY; RECURRENT; EXTREMITY; HEAT; TRIAL; MANAGEMENT; RADIATION
ISSN (print) / ISBN 0732-183X
e-ISSN 1527-7755
Zeitschrift Journal of Clinical Oncology - JCO
Quellenangaben Band: 20, Heft: , Seiten: 3156-3164 Artikelnummer: , Supplement: ,
Verlag American Society of Clinical Oncology
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) CCG Tumor Therapy with Hyperthermia (IMI-KTH)